Cargando…
Non-Clinical Contribution to Clinical Trials during Lead Optimization Phase
This manuscript comments on guidelines related to requirements for clinical trials for new drugs and the importance of considering regulatory criteria in the planning phase, in order to enhance the utility of data generated in basic research. Suggestions are made for optimizing regulatory management...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791035/ https://www.ncbi.nlm.nih.gov/pubmed/29364181 http://dx.doi.org/10.3390/bs8010017 |